P-046 Trial in progress: linvoseltamab, a BCMAxCD3 bispecific antibody, in a Phase 1b multi-cohort study of combination regimens for patients with relapsed/refractory multiple myeloma

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2023-09, Vol.23, p.S60-S60
Main Authors: Rodriguez-Otero, Paula, Joseph, Nisha, Kumar, Shaji, Leleu, Xavier, Manier, Salomon, Dimopoulos, Meletios, Mateos, Maria-Victoria, Oriol, Albert, Bumma, Naresh, Gong, Weiying, Roy, Pourab, Lorenc, Karen Rodriguez, Kroog, Glenn, Sarkaria, Shawn
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)01664-6